{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:18:44Z","timestamp":1791497924474,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1009 B02"],"award-info":[{"award-number":["SFB1009 B02"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lu477\/23-1"],"award-info":[{"award-number":["Lu477\/23-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IZKF","award":["EhC2\/006\/15"],"award-info":[{"award-number":["EhC2\/006\/15"]}]},{"name":"IZKF","award":["Lud2\/017\/13"],"award-info":[{"award-number":["Lud2\/017\/13"]}]},{"name":"IZKF","award":["Lud\/008\/17"],"award-info":[{"award-number":["Lud\/008\/17"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.antiviral.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T20:08:06Z","timestamp":1530994086000},"page":"80-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression"],"prefix":"10.1016","volume":"157","author":[{"given":"Tobias","family":"Schr\u00e4der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine E.","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Planz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.07.006_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8722-6-27","article-title":"MEK and the inhibitors: from bench to bedside","volume":"6","author":"Akinleye","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib2","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1128\/JVI.01258-12","article-title":"Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza a virus","volume":"87","author":"Alamares-Sapuay","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1074\/jbc.M113.469239","article-title":"Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection","volume":"289","author":"B\u00f6rgeling","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.07.006_bib4","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1038\/s41598-018-27445-7","article-title":"Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound","volume":"8","author":"Bruchhagen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.07.006_bib5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"Cheung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2018.07.006_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.07.006_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib8","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1128\/JVI.00533-10","article-title":"The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state","volume":"84","author":"Dudek","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1515\/BC.2011.174","article-title":"The influenza virus PB1-F2 protein has interferon antagonistic activity","volume":"392","author":"Dudek","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.07.006_bib10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/cmi.12108","article-title":"The NF-\u03baB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance","volume":"15","author":"Ehrhardt","year":"2013","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1470-2045(12)70269-3","article-title":"Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial","volume":"13","author":"Falchook","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-3-8","article-title":"From basic research to clinical development of MEK1\/2 inhibitors for cancer therapy","volume":"3","author":"Fr\u00e9min","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib13","first-page":"109","article-title":"Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: future compounds against influenza virus","volume":"55","author":"Gasparini","year":"2014","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.antiviral.2018.07.006_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","article-title":"GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition","volume":"17","author":"Gilmartin","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.antiviral.2013.03.006","article-title":"Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro","volume":"98","author":"Haasbach","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2017.03.024","article-title":"The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo","volume":"142","author":"Haasbach","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.antiviral.2011.07.006","article-title":"Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses","volume":"91","author":"Haasbach","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib18","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.07.006_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(12)70270-X","article-title":"Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial","volume":"13","author":"Infante","year":"2012","journal-title":"Lancet Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2018.07.006_bib20","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0264-410X(00)00275-9","article-title":"Inflammatory responses in influenza A virus infection","volume":"19","author":"Julkunen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.07.006_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cmi.12559","article-title":"Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity","volume":"18","author":"Kathum","year":"2016","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1200\/JCO.2012.43.5966","article-title":"Phase ii study of the MEK1\/MEK2 inhibitor trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor","volume":"31","author":"Kim","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-7961-1-1","article-title":"Mite and cockroach proteases activate p44\/p42 MAP kinases in human lung epithelial cells","volume":"1","author":"Kuderer","year":"2003","journal-title":"Clin. Mol. Allergy"},{"key":"10.1016\/j.antiviral.2018.07.006_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2012.09.013","article-title":"Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection","volume":"96","author":"Lee","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/jit463","article-title":"New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza a virus a\/PR8\/34 variant","volume":"209","author":"Liedmann","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.07.006_bib26","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","volume":"71","author":"Loregian","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2018.07.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkp161","article-title":"Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy","volume":"64","author":"Ludwig","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2018.07.006_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1471-4914(02)00010-2","article-title":"Influenza-virus-induced signaling cascades: targets for antiviral therapy?","volume":"9","author":"Ludwig","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2018.07.006_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(04)00108-5","article-title":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants","volume":"561","author":"Ludwig","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2018.07.006_bib30","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1074\/jbc.M510233200","article-title":"Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling","volume":"281","author":"Marjuki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.07.006_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1743-422X-4-134","article-title":"Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf\/MEK\/ERK signal cascade","volume":"4","author":"Marjuki","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2018.07.006_bib32","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib33","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1128\/JVI.03531-14","article-title":"Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes","volume":"89","author":"M\u00fchlbauer","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib34","first-page":"367","article-title":"Influenza virus and redox mediated cell signaling: a complex network of virus\/host interaction","volume":"30","author":"Nencioni","year":"2007","journal-title":"N. Microbiol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib35","doi-asserted-by":"crossref","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant","volume":"273","author":"Oliver","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.07.006_bib36","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1128\/JVI.01774-14","article-title":"Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo","volume":"88","author":"Perwitasari","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/adt.2015.0003.drrr","article-title":"Repurposing kinase inhibitors as antiviral agents to control influenza a virus replication","volume":"13","author":"Perwitasari","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","article-title":"Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo","volume":"92","author":"Pinto","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.antiviral.2013.04.008","article-title":"Development of cellular signaling pathway inhibitors as new antivirals against influenza","volume":"98","author":"Planz","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib40","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1515\/BC.2008.145","article-title":"RNA viruses and the mitogenic Raf\/MEK\/ERK signal transduction cascade","volume":"389","author":"Pleschka","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.07.006_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/35060098","article-title":"Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade","volume":"3","author":"Pleschka","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib42","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1099\/0022-1317-81-11-2697","article-title":"Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor","volume":"81","author":"Root","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/ars.2010.3512","article-title":"Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy","volume":"15","author":"Sgarbanti","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.antiviral.2018.07.006_bib45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1099\/vir.0.82483-0","article-title":"Effect of the phosphatidylinositol 3-kinase\/Akt pathway on influenza A virus propagation","volume":"88","author":"Shin","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1135(00)00171-1","article-title":"Cytokines in the pathogenesis of influenza","volume":"74","author":"Van Reeth","year":"2000","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib47","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbamcr.2006.11.009","article-title":"Clinical experience of MEK inhibitors in cancer therapy","volume":"1773","author":"Wang","year":"2007","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-1702(01)00263-5","article-title":"Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B","volume":"77","author":"Watanabe","year":"2001","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.07.006_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2015.08.008","article-title":"Influenza virus-host interactomes as a basis for antiviral drug development","volume":"14","author":"Watanabe","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib51","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40265-013-0096-1","article-title":"Trametinib: first global approval","volume":"73","author":"Wright","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2018.07.006_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.virol.2009.10.016","article-title":"Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model","volume":"396","author":"Wu","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.07.006_bib53","doi-asserted-by":"crossref","first-page":"30931","DOI":"10.1074\/jbc.M403258200","article-title":"NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas\/FasL is crucial for efficient influenza virus propagation","volume":"279","author":"Wurzer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.07.006_bib54","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/emboj\/cdg279","article-title":"Caspase 3 activation is essential for efficient influenza virus propagation","volume":"22","author":"Wurzer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2018.07.006_bib55","first-page":"23","article-title":"Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1\/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo","volume":"39","author":"Yamaguchi","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","author":"Zhao","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2018.07.006_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4161\/auto.5.3.7406","article-title":"Autophagy is involved in influenza A virus replication","volume":"5","author":"Zhou","year":"2009","journal-title":"Autophagy"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T22:00:18Z","timestamp":1534802418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":56,"alternative-id":["S0166354218303644"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.07.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}